0001493152-23-024969.txt : 20230719
0001493152-23-024969.hdr.sgml : 20230719
20230719210505
ACCESSION NUMBER: 0001493152-23-024969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230717
FILED AS OF DATE: 20230719
DATE AS OF CHANGE: 20230719
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossman Fred
CENTRAL INDEX KEY: 0001985154
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41583
FILM NUMBER: 231097940
MAIL ADDRESS:
STREET 1: C/O COYA THERAPEUTICS, INC.
STREET 2: 5850 SAN FELIPE ST., SUITE 500
CITY: HOUSTON
STATE: TX
ZIP: 77057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coya Therapeutics, Inc.
CENTRAL INDEX KEY: 0001835022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
BUSINESS PHONE: 650.739.3939
MAIL ADDRESS:
STREET 1: 12645 MEMORIAL DR., SUITE F1 #305
CITY: HOUSTON
STATE: TX
ZIP: 77024
4
1
ownership.xml
X0508
4
2023-07-17
0
0001835022
Coya Therapeutics, Inc.
COYA
0001985154
Grossman Fred
5850 SAN FELIPE ST.,
SUITE 500
HOUSTON,
TX
77057
0
1
0
0
Chief Medical Officer
0
Stock Option (right to buy)
4.25
2023-07-17
4
A
0
74069
A
2033-07-17
Common Stock, par value $0.0001 per share
74069
74069
D
Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024.
/s/ David Snyder, Attorney-in-Fact
2023-07-19